Abstract
This chapter reviews knowledge regarding the management of bipolar illness during pregnancy and in the postpartum (lactation) period. The natural course of bipolar illness during pregnancy and postpartum is discussed. Additionally, the chapter reviews information on the effects of medication exposure in utero and during lactation on the fetus and infant. General guidelines about treating bipolar disorder are given.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kessler, R. C., McGonagle, K. A., Swartz, M., Blazer, D. G., and Nelson, C. B. (1993) Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 29, 85–96.
Cohen, L. S., Altshuler, L. L., Stowe, Z. N., and Faraone, S. V. (2004) Reintroduc-tion of antidepressant therapy across pregnancy in women who previously discontinued treatment. A preliminary retrospective study. Psychother. Psychosom. 73, 255–258.
Altshuler, L. L., Cohen, L., Szuba, M. P., Burt, V. K., Gitlin, M., and Mintz, J. (1996) Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am. J. Psychiatry153, 592–606.
Grof, P., Robbins, W., Alda, M., Berghoefer, A., Vojtechovsky, M., Nilsson, A., and Robertson, C. (2000) Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J. Affect. Disord. 61, 31–39.
Kendell, R. E., Chalmers, J. C., and Platz, C. (1987) Epidemiology of puerperal psychoses. Br. J. Psychiatry 150, 662–673.
Terp, I. M. and Mortensen, P. B. (1998) Post-partumpsychoses. Clinical diagnoses and relative risk of admission after parturition. Br. J. Psychiatry 172, 521–526.
Freeman, M. P., Smith, K. W., Freeman, S. A., McElroy, S. L., Kmetz, G. E., Wright, R., and Keck, P. E., Jr. (2002) The impact of reproductive events on the course of bipolar disorder in women. J. Clin. Psychiatry 63, 284–287.
Viguera, A. C., Nonacs, R., Cohen, L. S., Tondo, L., Murray, A., and Baldessarini, R. J. (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am. J. Psychiatry 157, 179–184.
Kastrup, M., Lier, L., and Rafaelsen, O. J. (1989) Psychiatric illness in relation to pregnancy and childbirth, I: methodologic considerations. Nordisk Psykiatrisk Tidsskrift 45, 531–534.
Kendell, R. E., Wainwright, S., Hailey, A., and Shannon, B. (1976) The influence of childbirth on psychiatric morbidity. Psychol. Med. 6, 297–302.
Paffenberger, R. S. (1982) Epidemiological aspects of mental illness associated with childbirth. In: Brockington, I. F., Kumar, R., ed. Motherhood and Mental Illness. New York: Grune and Stratton, pp. 19–36.
Brockington, I. F., Cernik, K. F., Schofield, E. M., Downing, A. R., Francis, A. F., and Keelan, C. (1981) Puerperal psychosis. Phenomena and diagnosis. Arch. Gen. Psychiatry 38, 829–833.
Reich, T. and Winokur, G. (1970) Postpartum psychoses in patients with manic depressive disease. J. Nerv. Ment. Dis. 151, 60–68.
Suppes, T., Baldessarini, R. J., Faedda, G. L., and Tohen, M. (1991) Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch. Gen. Psychiatry 48, 1082–1088.
Faedda, G. L., Tondo, L., Baldessarini, R. J., Suppes, T., and Tohen, M. (1993) Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch. Gen. Psychiatry 50, 448–55.
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., and Altshuler, L. (2004) Management of bipolar disorder during pregnancy and the postpartum period. Am. J. Psychiatry161, 608–620.
Viguera, A. C., Cohen, L. S., Baldessarini, R. J., and Nonacs, R. (2002) Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can. J. Psychiatry 47, 426–136.
Burt, V. K. and Rasgon, N. (2004) Special considerations in treating bipolar disorder in women. Bipolar. Disord. 6, 2–13.
Thomas, P. and Severus W.E. (2003) Managing bipolar disorder during pregnancy and lactation: Is there a s afe and effective option ? European Psychiatry 18, 3s–8s.
Altshuler, L., Richards, M., and Yonkers, K. (2003) Treating bipolar disorder during pregnancy. Current Psychiatry 2, 15–25.
Orr, S. T. and Miller, C. A. (1995) Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiol. Rev. 17, 165–171.
Steer, R. A., Scholl, T. O., Hediger, M. L., and Fischer, R. L. (1992) Self-reported depression and negative pregnancy outcomes. J. Clin. Epidemiol. 45, 1093–1099.
Hedegaard, M., Henriksen, T. B., Sabroe, S., and Secher, N. J. (1993) Psychological distress in pregnancy and preterm delivery. BMJ 307, 234–239.
Glover, V. and O’Connor, T. G. (2002) Effects of antenatal stress and anxiety: Implications for development and psychiatry. Br. J. Psychiatry 180, 389–391.
O’Connor, T. G., Heron, J., Golding, J., Beveridge, M., and Glover, V. (2002) Maternal antenatal anxiety and children’s behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children. Br. J. Psychiatry 180, 502–508.
Weinstock, L., Cohen, L. S., Bailey, J. W., Blatman, R., and Rosenbaum, J. F. (2001) Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series. Psychother. Psychosom. 70, 158–162.
Nelson, K. and Holmes, L. B. (1989) Malformations due to presumed spontaneous mutations in newborn infants. N. Engl. J. Med. 320, 19–23.
Cohen, L. S., Friedman, J. M., Jefferson, J. W., Johnson, E. M., and Weiner, M. L. (1994) A reevaluation of risk of in utero exposure to lithium. JAMA 271, 146–150.
Cohen, L. S. and Rosenbaum, J. F. (1998) Psychotropic drug use during pregnancy: weighing the risks.J. Clin. Psychiatry 59(Suppl.2), 18–28.
Schou, J. (1976) [Drugs and fetal development]. Ugeskr. Laeger 138: 2174.
Heinonen, O. P., Slone, D., and Shapiro, S. (1999) Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group.
Tomson, T. and Battino, D. (2005) Teratogenicity of antiepileptic drugs: state of the art. Curr. Opin. Neurol. 18, 135–140.
Impastato, D. J., Gabriel, A. R., and Lardaro, H. H. (1964) Electric and insulin shock therapy during pregnancy. Dis. Nerv. Syst. 25, 542–546.
Jager-Roman, E., Deichl, A., Jakob, S., Hartmann, A. M., Koch, S., Rating, D., Steldinger, R., Nau, H., and Helge, H. (1986) Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J. Pediatr. 108, 997–1004.
Koch, K., Hartman, A., Jager-Roman, E., Rating, D., and Helge, H. (1982) Major malformations of children of epileptic parents-due to epilepsy or its therapy? In: Janz, D., Bossi, L., Dam, M., Helge, H., Richens, A., Schmidt, D., eds. Epilepsy, Pregnancy and the Child. New York: Raven Press, pp. 313–316.
Omtzigt, J. G., Los, F. J., Hagenaars, A. M., Stewart, P. A., Sachs, E. S., and Lindhout, D. (1992) Prenatal diagnosis of spina bifida aperta after first-trimester valproate exposure. Prenat. Diagn. 12, 893–897.
Rosa, F. W. (1991) Spina bifida in infants of women treated with carbamazepine during pregnancy. N. Engl. J. Med. 324, 674–677.
Delgado-Escueta, A. V. and Janz, D. (1992) Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 42, 149–160.
Gaily, E. and Granstrom, M. L. (1992) Minor anomalies in children of mothers with epilepsy. Neurology 42, 128–131.
Jones, K. L., Lacro, R. V., Johnson, K. A., and Adams, J. (1989) Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N. Engl. J. Med. 320, 1661–1666.
Kennedy, D. and Koren, G. (1998) Valproic acid use in psychiatry: issues in treating women of reproductive age. J. Psychiatry Neurosci. 23, 223–228.
Felding, I. and Rane, A. (1984) Congenital liver damage after treatment of mother with valproic acid and phenytoin? Acta Paediatr. Scand. 73, 565–568.
Thisted, E. and Ebbesen, F. (1993) Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch. Dis. Child 69, 288–291.
Majer, R. V. and Green, P. J. (1987) Neonatal afibrinogenaemia due to sodium valproate. Lancet 2, 740–741.
DiLiberti, J. H., Farndon, P. A., Dennis, N. R., and Curry, C. J. (1984) The fetal valproate syndrome. Am. J. Med. Genet. 19, 473–481.
Lindhout, D., Meinardi, H., Meijer, J. W., and Nau, H. (1992) Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology 42, 94–110.
Frey, B., Schubiger, G., and Musy, J. P. (1990) Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breastfeeding. Eur. J. Pediatr. 150, 136–138.
Merlob, P., Mor, N., and Litwin, A. (1992) Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding. Ann. Pharmacother. 26, 1563–1565.
Scolnik, D., Nulman, I., Rovet, J., Gladstone, D., Czuchta, D., Gardner, H. A., Gladstone, R., Ashby, P., Weksberg, R., Einarson, T., et al. (1994) Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271, 767–770.
Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L., and Monaghan, E. T. (2000) A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J. Clin. Psychiatry 61, 841–850.
Calabrese, J.R., Shelton, M. D., Rapport, D. J., Kimmel, S. E., and Elhaj, O. (2002) Long-term treatment of bipolar disorder with lamotrigine. J. Clin. Psychiatry 63(Suppl. 10), 18–22.
Ohman, I., Vitols, S., and Tomson, T. (2000) Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 41, 709–713.
Mackay, F. J., Wilton, L. V., Pearce, G. L., Freemantle, S. N., and Mann, R. D. (1997) Safety of long-term lamotrigine in epilepsy. Epilepsia 38, 881–886.
Rumeau-Rouquette, C., Goujard, J., and Huel, G. (1977) Possible teratogenic effect of phenothiazines in human beings. Teratology 15, 57–64.
Slone, D., Siskind, V., Heinonen, O. P., Monson, R. R., Kaufman, D. W., and Shapiro, S. (1977) Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am. J. Obstet. Gynecol. 128, 486–88.
Sobel, D. E. (1960) Fetal damage due to ECT, insulin coma, chlorpromazine, or reserpine. Arch. Gen. Psychiatry 2, 606–611.
Sexson, W. R. and Barak, Y. (1989) Withdrawal emergent syndrome in an infant associated with maternal haloperidol therapy. J. Perinatol. 9, 170–172.
Ayd, F. J., Jr. (1968) Is psychiatry in a crisis because of the complications of the psychopharmaceuticals? Dis. Nerv. Syst. 29,Suppl. 5.
Edlund, M. J. and Craig, T. J. (1984) Antipsychotic drug use and birth defects: an epidemiologic reassessment. Compr. Psychiatry 25, 32–37.
Goldstein, D. J., Corbin, L. A., and Fung, M. C. (2000) Olanzapine-exposed pregnancies and lactation: early experience. J. Clin. Psychopharmacol. 20, 399–403.
Littrell, K. H., Johnson, C. G., Peabody, C. D., and Hilligoss, N. (2000) Antipsychotics during pregnancy. Am. J. Psychiatry 157, 1342.
Waldman, M. D. and Safferman, A. Z. (1993) Pregnancy and clozapine. Am. J. Psychiatry 150, 168–169.
Dickson, R. A. and Hogg, L. (1998) Pregnancy of a patient treated with clozapine. Psychiatr. Serv. 49, 1081–1083.
Stone, S. C., Sommi, R. W., Marken, P. A., Anya, I., and Vaughn, J. (1997) Clozapine use in two full-term pregnancies (letter). J. Clin. Psychiatry 58, 364–365.
Gentile, S. (2004) Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann. Pharmacother. 38, 1265–1271.
Koren, G., Cohn, T., Chitayat, D., Kapur, B., Remington, G., Reid, D. M., and Zipursky, R. B. (2002) Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. Am. J. Psychiatry159: 136–137.
McKenna, K., Levinson, A. J., Einarson, A., Diav-Citrin, O., Zipursky, R. B., and Koren, G. (2003) Pregnancy outcome in women receiving atypical antipsychotic drugs: A prospective, multicentre, comparative study. Birth Defects Res. 67: 391.
Dicke, J. M. (1989) Teratology: principles and practice. Med. Clin. North Am. 73, 567–582.
Langman, J. (1975) Medical Embryology: Human Development—Normal and Abnormal, 3rd ed. Baltimore: Williams & Wilkins.
Milkovich, L. and van den Berg, B. J. (1974) Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N. Engl. J. Med. 291, 1268–1271.
Aarskog, D. (1975) Letter: Association between maternal intake of diazepam and oral clefts. Lancet 2, 921.
Crombie, D. L., Pinsent, R. J., Fleming, D. M., Rumeau-Rouquette, C., Goujard, J., and Huel, G. (1975) Letter: fetal effects of tranquilizers in pregnancy. N. Engl. J. Med. 293, 198–199.
Hartz, S.C., Heinonen, O.P., Shapiro S., Siskind, V., and Slone, D. (1975) Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. N. Engl. J. Med. 292, 726–728.
Safra, M. J. and Oakley, G. P., Jr. (1975) Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2, 478–480.
Saxen, I. and Saxen, L. (1975) Letter: association between maternal intake of diazepam and oral clefts. Lancet 2, 498.
Czeizel, A. (1976) Letter: diazepam, phenytoin, and aetiology of cleft lip and/or cleft palate. Lancet 1, 810.
Czeizel, A. and Racz, J. (1990) Evaluation of drug intake during pregnancy in the Hungarian Case-Control Surveillance of Congenital Anomalies. Teratology 42, 505–512.
Czeizel, A. and Lendvay, A. (1987) In-utero exposure to benzodiazepines (letter).Lancet 1, 628.
Rosenberg, L., Mitchell, A. A., Parsells, J. L., Pashayan, H., Louik, C., and Shapiro, S.( 1983) Lack of relation of oral clefts to diazepam use during pregnancy. N. Engl. J. Med. 309, 1282–1285.
Shiono, P. H. and Mills, J. L. (1984) Oral clefts and diazepam use during pregnancy. N. Engl. J. Med. 311, 919–920.
Laegreid, L., Olegard, R., Conradi, N., Hagberg, G., Wahlstrom, J., and Abrahamsson, L. (1990) Congenital malformations and maternal consumption of benzodiazepines: a case-control study. Dev. Med. Child Neurol. 32, 432–441.
Bergman, U., Rosa, F. W., Baum, C., Wiholm, B. E., and Faich, G. A. (1992) Effects of exposure to benzodiazepine during fetal life. Lancet 340, 694–696.
StClair, S.M. and Schirmer, R. G. (1992) First-trimester exposure to alprazolam. Obstet. Gynecol. 80, 843–846.
Dolovich, L. R., Addis, A., Vaillancourt, J. M., Power, J. D., Koren, G., and Einarson, T. R. (1998) Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ 317, 839–843.
Bonnot, O., Vollset, S. E., Godet, P. F., d’Amato, T., Dalery, J., and Robert, E. (2003) [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?]. Encephale 29, 553–559.
McElhatton, P. R. (1994) The effects of benzodiazepine use during pregnancy and lactation. Reprod. Toxicol. 8, 461–475.
Fisher, J. B., Edgren, B. E., Mammel, M. C., and Coleman, J. M. (1985) Neonatal apnea associated withmaternalclonazepam therapy: a casereport. Obstet. Gynecol. 66, 34S–35S.
Gillberg, C. (1977) "e;Floppy infant syndrome"e; and maternal diazepam. Lancet 2, 244.
Mazzi, E. (1977) Possible neonatal diazepam withdrawal: a case report. Am. J. Obstet. Gynecol. 129, 586–587.
Rementeria, J. L. and Bhatt, K. (1977) Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J. Pediatr. 90, 123–126.
Rowlatt, R.J. (1978) Effect of maternal diazepam on the newborn. Br. Med J. 1,985.
Speight, A. N. (1977) Floppy-infant syndrome and maternal diazepam and/or nitrazepam. Lancet 2, 878.
Whitelaw, A. G., Cummings, A. J., and McFadyen, I. R. (1981) Effect of maternal lorazepam on the neonate. Br. Med J. (Clin. Res. Ed.) 282, 1106–1108.
Laegreid, L., Hagberg, G., and Lundberg, A. (1992) Neurodevelopment in late infancy after prenatal exposure to benzodiazepines—a prospective study. Neuropediatrics 23, 60–67.
Ferrill, M. J., Kehoe, W. A., and Jacisin, J. J. (1992) ECT during pregnancy: physiologic and pharmacologic considerations. Convuls. Ther. 8, 186–200.
Miller, L. J. (1994) Use of electroconvulsive therapy during pregnancy. Hosp. Commun. Psychiatry45, 444–450.
Dansky, L. V., Rosenblatt, D. S., and Andermann, E. (1992) Mechanisms of ter-atogenesis: folic acid and antiepileptic therapy 1. Neurology 42, 32–42.
Cochran, S. D. (1984) Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J. Consult. Clin. Psychol. 52, 873–878.
Ehlers, C. L., Frank, E., and Kupfer, D. J. (1988) Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression. Arch. Gen. Psychiatry 45, 948–952.
Spinelli, M. G. (1997) Interpersonal psychotherapy for depressed antepartum women: a pilot study. Am. J. Psychiatry 154, 1028–1030.
Kraepelin, E. (1921) Manic-depressive insanity and paranoia. (Translation of: Psychiatrie: Ein Kurzes Lehrbuch für Studierende und Ärtze, 8th ed.) Edinburgh: Livingstone.
Kendell, R. E., Wainwright, S., Hailey, A., and Shannon, B. (1976) The influence of childbirth on psychiatric morbidity. Psychol. Med. 6, 297–302.
Baldessarini, R. J., Tondo, L., and Viguera, A. C. (1999) Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. B ipolar Disord. 1, 17–24.
Braftos, O. H. J. (1966) Puerperal mental disorders in manic depressive females. Acta Psychiatr. Scand. 42, 285–294.
Reich, T. and Winokur, G. (1970) Postpartum psychoses in patients with manic depressive disease. J. Nerv. Ment. Dis. 151, 60–68.
Davidson, J. and Robertson, E. (1985) A follow-up study of post partum illness, 1946-1978. Acta Psychiatr. Scand. 71, 451–457.
Klompenhouwer, J. L. and van Hulst, A. M. (1991) Classification of postpartum psychosis: a study of 250 mother and baby admissions in The Netherlands. Acta Psychiatr. Scand. 84, 255–261.
Rhode, A. and Marneros, A. (2000) Bipolar disorders during pregnancy, postpartum, and in menopause. In: Marners, A. and Angst, J., ed. Bipolar Disorders: 100 Years After Manic-Depressive Insanity. London: Kluwer Academic Publishers, pp. 127–137.
Blehar, M., DePaulo J., and Gershon, E. (1988) Women with bipolar disorder: findings from the NIMH genetics intiative sample. Psychopharmacol. Bull. 34, 239–243.
Kruger, S. and Braunig, P. (2002) Clinical issues in bipolar disorder during pregnancy and the pospartum period. Clin. Approaches Bipolar Disord. 1, 65–71.
Cohen, L. S., Sichel, D. A., Robertson, L. M., Heckscher, E., and Rosenbaum, J. F. (1995) Postpartum prophylaxis for women with bipolar disorder. Am. J. Psychiatry 152, 1641–1645.
Curtis, V. (2005) Women are not the same as men: specific clinical issues for female patients with bipolar disorder. Bipolar Disord. 7 (Suppl 1), 16–24.
Leibenluft, E. (2000) Women and bipolar disorder: an update. Bull. Menninger Clin. 64, 5–17.
Parry, B. L. (1989) Reproductive factors affecting the course of affective illness in women. Psychiatr Clin. North Am. 12, 207–220.
Wisner, K. L., Hanusa, B. H., Peindl, K. S., and Perel, J. M. (2004) Prevention of postpartum episodes in women with bipolar disorder. Biol. Psychiatry 56, 592–596.
Altshuler, L. L., Hendrick, V., and Cohen, L. S. (1998) Course of mood and anxiety disorders during pregnancy and the postpartum period. J. Clin. Psychiatry 59 (Suppl. 2), 29–33.
Chaudron, L. H. and Pies, R. W. (2003) The relationship between postpartum psychosis and bipolar disorder: a review. J. Clin. Psychiatry 64, 1284–1292.
Sharma, V. and Mazmanian, D. (2003) Sleep loss and postpartum psychosis. Bipolar Disord. 5, 98–105.
Strouse, T. B., Szuba, M. P., and Baxter, L. R., Jr. (1992) Response to sleep deprivation in three women with postpartum psychosis. J. Clin. Psychiatry 53, 204–206.
Dean, C., Williams, R. J., and Brockington, I. F. (1989) Is puerperal psychosis the same as bipolar manic-depressive disorder? A family study. Psychol. Med. 19, 637–647.
McNeil, T. F. (1987) A prospective study of postpartum psychoses in a high-risk group. 2. Relationships to demographic and psychiatric history characteristics. Acta Psychiatr. Scand. 75, 35–43.
Suri, R. and Burt, V. K. (1997) The assessment and treatment of postpartum psychiatric disorders. J. Pract. Psychiatry Behav. Health 3, 67–77.
Pariser, S. F. (1993) Women and mood disorders. Menarche to menopause.Ann. Clin. Psychiatry 5, 249–254.
Stewart, D. E. (1988) Prophylactic lithium in postpartum affective psychosis. J Nerv. Ment. Dis. 176, 485–489.
Stewart, D. E., Klompenhouwer, J. L., Kendell, R. E., and van Hulst, A. M. (1991) Prophylactic lithium in puerperal psychosis. The experience of three centres. Br. J. Psychiatry 158, 393–397.
Austin, M. P. (1992) Puerperal affective psychosis: is there a case for lithium prophylaxis? Br. J. Psychiatry 161, 692–694.
Abou-Saleh, M. T. and Coppen, A. (1983) Puerperal affective disorders and response to lithium. Br. J. Psychiatry 142, 539.
van Gent, E. M. and Verhoeven, W. M. (1992) Bipolar illness, lithium prophylaxis, and pregnancy. Pharmacopsychiatry 25, 187–191.
Rohde, A. and Marneros, A. (1993) Postpartum psychoses: onset and long-term course. Psychopathology 26, 203–209.
Protheroe, C. (1969) Puerperal psychoses: a long term study 1927-1961. Br. J. Psychiatry 115, 9–30.
Videbech, P. and Gouliaev, G. (1995) First admission with puerperal psychosis: 7-14 years of follow-up. Acta Psychiatr Scand. 91, 167–173.
Wisner, K. L., Peindl, K., and Hanusa, B. H. (1994) Symptomatology of affective and psychotic illnesses related to childbearing. J. Affect. Disord. 30, 77–87.
Brokington, I. (1999) Infanticide Motherhood and Mental Health. New York: Oxford University Press, pp. 430–468.
d’Orban, P. T. (1979) Women who kill their children. Br. J. Psychiatry 134, 560–571.
Platz C. and Kendell, R. E. (1988) A matched-control follow-up and family study of’ puerperalpsychoses’. Br. J. Psychiatry 153, 90–94.
Whalley, L. J., Roberts, D. F., Wentzel, J., and Wright, A. F. (1982) Genetic factors in puerperal affective psychoses. Acta Psychiatr. Scand. 65, 180–193.
Jones I. and Craddock, N. (2001) Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am. J. Psychiatry 158, 913–917.
Coyle, N., Jones, I., Robertson, E., Lendon, C., and Craddock, N. (2000) Variation at the serotonin transporter gene influences susceptibility to bipolar affective puerperal psychosis. Lancet 356, 1490–1491.
Wisner, K. Prevention of postpartum episodes in bipolar women [abstract]. (1997) In: Syllabus and Proceedings Summary of the 151st Ann Meeting American Psychiatric Association (May 17-22) Toronto (ON). Washington, DC, American Psychiatric Association.
Viguera, A. C. and Cohen, L. S. (1998) The course and management of bipolar disorder during pregnancy. Psychopharmacol. Bull. 34, 339–346.
Burt, V. K., Suri, R., Altshuler, L., Stowe, Z., Hendrick, V. C., and Muntean, E. (2001) The use of psychotropic medications during breast-feeding. Am. J. Psychiatry 158, 1001–1009.
(2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108, 776–789.
Ito, S. (2000) Drug therapy for breast-feeding women. N. Engl. J. Med. 343, 118–126.
Ernst, C. L. and Goldberg, J. F. (2002) The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psycho tropics. J. Clin. Psychiatry 63 (Suppl. 4), 42–55.
Llewellyn, A., Stowe, Z. N., and Strader, J. R., Jr. (1998) The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J. Clin. Psychiatry 59 (Suppl. 6), 57–64.
Targum, S. D., Davenport, Y. B., and Webster, M. J. (1979) Postpartum mania in bipolar manic-depressive patients withdrawn from lithium carbonate. J. Nerv. Ment. Dis. 167, 572–574.
Chaudron, L. H. and Jefferson, J. W. (2000) Mood stabilizers during breastfeeding: a review. J. Clin. Psychiatry 61, 79–90.
Leibenluft, E. (1997) Issues in the treatment of women with bipolar illness. JClin. Psychiatry 58 (Suppl. 15), 5–11.
Physicians’ Desk Reference (2001) Montvale, NJ: Medical Economics Company, Inc.
Holmes, L.B., Harvey E. A., Coull B. A., Huntingto, K.B., Khoshbi, S., Haye, A. M., and Ryan, L. M. (2001) The teratogenicity of anticonvulsant drugs. N. Engl. J. Med. 344, 1132–1138.
Wisner K. L. and Perel, J. M. (1998) Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. J. Clin. Psychopharmacol. 18, 167–169.
Stah, M. M., Neiderud, J., and Vinge, E. (1997) Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J. Pediatr. 130, 1001–1003.
Physicians’ Desk Reference (2001). Montvale, NJ: Medical Economics Company, Inc.
Iqbal, M. M., Gundlapalli, S. P., Ryan, W. G., Ryals, T., and Passman, T. E. (2001) Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants. South. Med. J. 94, 304–322.
Kuhnz, W., Jager-Roman, E., Rating, D., Deichl, A., Kunze, J., Helge, H., and Nau, H. (1983) Carbamazepine and carbamazepine-10,11-epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects. Pediatr. Pharmacol. (New York) 3, 199–208.
Kaneko, S., Suzuki, K., Sato, T., et al. (1982) The problems of antiepileptic medication in the neonatal period: is breast-feeding advisable? In Janz, D., Dam, M., Richens, A., eds. Epilepsy, Pregnancy, and the Child. New York: Raven Press, pp. 343–348.
Niebyl, J. R., Blake, D. A., Freeman, J. M., and Luff, R. D. (1979) Carbamazepine levels in pregnancy and lactation. Obstet. Gynecol. 53, 139–140.
Tomson, T., Ohman, I., and Vitols, S. (1997) Lamotrigine in pregnancy and lactation: a case report. Epilepsia 38, 1039–1041.
Ohman, I., Tomson, T., and Vitols, S. (1998) Lamotrigine levels in plasma and breast milk in nursing women and their infants. Epilepsia 21(Suppl. 2), 39.
Sabers, A., Buchholt, J. M., Uldall, P., and Hansen, E. L. (2001) Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res. 47, 151–154.
von Unruh, G. E., Froescher, W., Hoffmann, F., and Niesen, M. (1984) Valproic acid in breast milk: how much is really there? Ther. Drug Monit. 6, 272–276.
Malone, K., Papagni, K., Ramini, S., and Keltner, N. L. (2004) Antidepressants, antipsychotics, benzodiazepines, and the breastfeeding dyad. Perspect. Psychiatr. Care 40, 73–85.
Clozaril product information (2001) In: Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., pp. 2155–2159.
Risperdal product information (2001) In: Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., pp. 1580–1584.
Aripiprazole. Drugdex Drug Evaluations (1974-2003). Thomson MICROMEDEX, Healthcare Series (Vol. 117).
Yoshida, K., Smith, B., Craggs, M., and Kumar, R. (1998) Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breastfed infants. Psychol. Med. 28, 81–91.
Zarate, C. A., Jr. (2000) Antipsychotic drug side effect issues in bipolar manic patients. J Clin. Psychiatry 61 (Suppl. 8), 52–61.
Goodwin, F. K. and Jamison, K. R. (1990) Manic depressive illness. In: Clinical Guidelines. New York: Oxford University Press, pp. 665–724.
(2002) Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 159, 1–50.
Patrick, M. J., Tilstone, W. J., and Reavey, P. (1972) Diazepam and breast-feeding. Lancet 1, 542–543.
Iqbal M. M., Sobhan T., and Ryals, T. (2002) Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr. Serv. 53, 39–49.
Darwish, M., Martin, P. T., Cevallos, W. H., Tse, S., Wheeler, S., and Troy, S. M. (1999) Rapid disappearance of zaleplon from breast milk after oral administration to lactating women. J. Clin. Pharmacol. 39, 670–674.
Miller, L. J. (2002) Postpartum depression. JAMA 287, 762–765.
McElroy, S. L. (2004) Bipolar disorders: special diagnostic and treatment considerations in women. CNS Spectr. 9, 5–18.
McElroy, S. L., Arnold, L. M., and Altshuler, L. L. (2005) Bipolarity in women: therapeutic issues. In: Akiskal, H. S., Tohen, M., ed. Bipolar Psychopharmacotherapy: Caring for the Patient. John Wiley & Sons, Ltd.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Altshuler, L.L., Kiriakos, C. (2006). Bipolar Disorder. In: Hendrick, V. (eds) Psychiatric Disorders in Pregnancy and the Postpartum. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-013-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-59745-013-3_5
Publisher Name: Humana Press
Print ISBN: 978-1-58829-486-9
Online ISBN: 978-1-59745-013-3
eBook Packages: MedicineMedicine (R0)